Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (59)
  • 2024 (40)
  • 2023 (76)
  • 2022 (84)
  • 2021 (70)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (364)
  • Other (8)

Drug Name

  • Oxycodone (75)
  • Opioids (57)
  • Fentanyl (54)
  • Synthetic Opioids (21)
  • Hydromorphone (18)
  • Methamphetamine (14)
  • Benzodiazepines (13)
  • Morphine (10)
  • Amphetamines (9)
  • Cocaine (9)
  • Heroin (7)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (34)
  • New England (24)
  • Seattle (23)
  • Sede (22)
  • Atlanta (19)
  • Chicago (18)
  • Miami (18)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (12)
  • San Francisco (12)
  • Los Angeles (10)
  • Louisville (10)
  • New Orleans (10)
  • Omaha (10)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Drug Enforcement Administration El Paso Division Announces Spring Take Back Day

Abril 05, 2023
El Paso, Texas – The Drug Enforcement Administration has announced the date of its 24th National Prescription Drug Take Back Day. On Saturday, April 22, DEA and its partners will collect tablets, capsules, patches, and other solid forms of prescription drugs. For more than a decade, DEA’s National Prescription Drug...
Abril 05, 2023
PRESS RELEASE

DEA to host summit on Medication for Opioid Use Disorder (MOUD) in Charleston, WV

Abril 04, 2023
Louisville, Ky. – The Drug Enforcement Administration (DEA) and the State of West Virginia are hosting a discussion on Medication for Opioid Use Disorder (MOUD) in Charleston, West Virginia on Saturday, April 15, 2023 from 12:00 p.m. to 5:00 p.m. The event will take place at the University of Charleston’s...
Abril 04, 2023
PRESS RELEASE

Former Health Care Worker Sentenced for Fentanyl Thefts

Marzo 29, 2023
KANSAS CITY, Kan. – A former nurse was sentenced to 12 months and a day in prison for stealing fentanyl from two hospitals where she worked. Faith Naccarato, 42, of Kansas City, Missouri, pleaded guilty to two counts of tampering with a consumer product and two counts of possession of...
Marzo 29, 2023
PRESS RELEASE

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations

Marzo 24, 2023
INDIANAPOLIS - A joint investigation by Drug Enforcement Administration-Indianapolis and the Indianapolis Metropolitan Police Department (IMPD) has led to the arrest of Zennon Gaines, a pharmacy technician from Indianapolis, who has been charged with multiple violations, including felony dealing and possession of a controlled substance by fraud/forgery. The joint investigation...
Marzo 24, 2023
PRESS RELEASE

Former Nurse Sentenced for Stealing Opioids from Kansas Hospital

Marzo 13, 2023
KANSAS CITY, Kan. – A Kansas man was sentenced to 18 months in prison and his nursing license forfeited after stealing controlled substances from his employer. According to court documents, in March 2021, Alec Ramirez, 32, of Overland Park, Kan., removed vials of fentanyl and hydromorphone from an automated dispensing...
Marzo 13, 2023
PRESS RELEASE

Nurse at St. Louis County Hospital Sentenced to Four Years of Probation for Fraudulently Obtaining Fentanyl

Marzo 09, 2023
ST. LOUIS – U.S. District Judge Stephen R. Clark on Thursday sentenced a former nurse at a St. Louis County, Missouri, hospital to four years of probation for fraudulently obtaining fentanyl for her own use. From Jan. 18, 2020 to Feb. 2, 2020, Lindsay J. Maupin, of Cape Girardeau, Mo...
Marzo 09, 2023
PRESS RELEASE

Indiana Man Sentenced to 5 Years' Probation for Obtaining a Controlled Substance by Deception

Marzo 08, 2023
FORT WAYNE, Ind. – Alfred A. Cooke, Assistant Special Agent in Charge of Drug Enforcement Administration-Merrillville, Indiana, and U.S. Attorney Clifford D. Johnson for the Northern District of Indiana announced that Lucian Boboia, age 49, of Phoenix, Arizona, was sentenced before U.S. District Court Judge Holly A. Brady after pleading...
Marzo 08, 2023
PRESS RELEASE

Former State Lawmaker Sentenced for COVID-19 Fraud Scheme at Springfield Health Care Charity

Febrero 28, 2023
SPRINGFIELD, Mo. – A former Missouri state representative was sentenced in federal court today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and for...
Febrero 28, 2023
PRESS RELEASE

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

Febrero 24, 2023
WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...
Febrero 24, 2023
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

Febrero 15, 2023
NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
Febrero 15, 2023
Showing 161 - 170 of 372 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 13
  • Página 14
  • Página 15
  • Página 16
  • Current page 17
  • Página 18
  • Página 19
  • Página 20
  • Página 21
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster